Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.82% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.26% |
| 4 | Consumer Discretionary | 1.92% |
| 5 | Industrials | 1.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
176
CALL
Accenture
ACN
$110B
| $295M | 0.08% |
1,064,100
+339,200
| +47% | +$102M |
|
177
CALL
Verizon
VZ
$196B
| $295M | 0.08% |
5,807,000
+1,443,700
| +33% | +$73M |
|
178
Goldman Sachs
GS
$301B
| $293M | 0.08% |
986,428
+657,514
| +200% | +$205M |
|
|
179
CALL
lululemon athletica
LULU
$14.3B
| $290M | 0.07% |
1,065,600
+398,900
| +60% | +$128M |
|
180
PUT
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.7B
| $290M | 0.07% |
4,214,600
+612,800
| +17% | +$48.3M |
|
181
CALL
VanEck Semiconductor ETF
SMH
$70.6B
| $289M | 0.07% |
2,839,600
-465,400
| -14% | -$54M |
|
182
PUT
Coca-Cola
KO
$372B
| $289M | 0.07% |
4,591,000
+781,200
| +21% | +$49.5M |
|
183
CALL
Cigna
CI
$72.4B
| $285M | 0.07% |
1,080,900
+231,300
| +27% | +$59.6M |
|
184
CALL
Micron Technology
MU
$981B
| $285M | 0.07% |
5,149,700
-234,500
| -4% | -$15.9M |
|
185
CALL
Zscaler
ZS
$28.9B
| $281M | 0.07% |
1,881,800
+165,700
| +10% | +$29.3M |
|
186
CALL
Lam Research
LRCX
$390B
| $281M | 0.07% |
6,584,000
+961,000
| +17% | +$45.7M |
|
187
CALL
Baidu
BIDU
$35.9B
| $277M | 0.07% |
1,865,300
-44,500
| -2% | -$5.88M |
|
188
PUT
General Motors
GM
$78.4B
| $277M | 0.07% |
8,717,100
+163,700
| +2% | +$6.14M |
|
|
189
PUT
Eli Lilly
LLY
$1.08T
| $276M | 0.07% |
852,700
-84,800
| -9% | -$25.5M |
|
190
CALL
Caterpillar
CAT
$388B
| $276M | 0.07% |
1,545,600
-38,100
| -2% | -$8.03M |
|
191
PUT
Morgan Stanley
MS
$338B
| $273M | 0.07% |
3,594,600
-423,700
| -11% | -$34.7M |
|
192
CALL
iShares MSCI Emerging Markets ETF
EEM
$29.9B
| $273M | 0.07% |
6,799,500
+626,500
| +10% | +$26.3M |
|
193
PUT
Target
TGT
$69.2B
| $273M | 0.07% |
1,929,600
+852,700
| +79% | +$163M |
|
194
CALL
Merck
MRK
$322B
| $271M | 0.07% |
2,969,500
-656,900
| -18% | -$58.2M |
|
195
PUT
Ulta Beauty
ULTA
$23.3B
| $270M | 0.07% |
700,000
+419,000
| +149% | +$167M |
|
|
196
ResMed
RMD
$32.6B
| $268M | 0.07% |
+1,280,595
| New | +$273M |
|
197
CALL
Intuitive Surgical
ISRG
$142B
| $267M | 0.07% |
1,328,300
+451,100
| +51% | +$106M |
|
198
CALL
Elevance Health
ELV
$84.7B
| $265M | 0.07% |
548,200
+333,200
| +155% | +$165M |
|
199
PUT
iShares MSCI Brazil ETF
EWZ
$8.6B
| $264M | 0.07% |
9,652,700
+3,944,200
| +69% | +$131M |
|
|
200
lululemon athletica
LULU
$14.3B
| $264M | 0.07% |
967,492
+938,277
| +3,212% | +$301M |
|
Similar funds
Citadel Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
- Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.